Literature DB >> 11441101

Regulation of complement classical pathway by association of C4b-binding protein to the surfaces of SK-OV-3 and Caov-3 ovarian adenocarcinoma cells.

M T Holmberg1, A M Blom, S Meri.   

Abstract

The role of fluid-phase regulators of complement is to inhibit excessive complement activation and maintain homeostasis in blood. By binding to and inactivating complement components on cell surfaces, they can also protect autologous cells from complement-mediated cytotoxicity and phagocytosis. In this study, we wanted to find out whether C4b-binding protein (C4bp), a fluid-phase regulator of the classical complement pathway, could directly bind to cell surfaces in a functionally active form. After screening several malignant cell lines, we observed that the ovarian adenocarcinoma cell lines SK-OV-3, Caov-3, and SW626 were capable of binding C4bp. Binding tests with recombinant deletion mutants suggested that the primary binding site on C4bp is located on the alpha-chain complement control protein 4 domain. Functional tests showed that tumor cell-bound C4bp retained its cofactor activity for factor I-mediated inactivation of C4b, thus increasing the control of classical complement pathway activation on the surfaces of these cells. These results demonstrate a novel mechanism of complement regulation on cell surfaces, particularly on those of malignant ovarian tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441101     DOI: 10.4049/jimmunol.167.2.935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Complement in cancer: untangling an intricate relationship.

Authors:  Edimara S Reis; Dimitrios C Mastellos; Daniel Ricklin; Alberto Mantovani; John D Lambris
Journal:  Nat Rev Immunol       Date:  2017-09-18       Impact factor: 53.106

2.  Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.

Authors:  Panisadee Avirutnan; Richard E Hauhart; Pawit Somnuke; Anna M Blom; Michael S Diamond; John P Atkinson
Journal:  J Immunol       Date:  2011-06-03       Impact factor: 5.422

3.  Epididymal C4b-binding protein is processed and degraded during transit through the duct and is not essential for fertility.

Authors:  Mayumi I Nonaka; Eva Zsigmond; Akihiko Kudo; Hayato Kawakami; Kaoru Yoshida; Manabu Yoshida; Natsuko Kawano; Kenji Miyado; Masaru Nonaka; Rick A Wetsel
Journal:  Immunobiology       Date:  2014-11-11       Impact factor: 3.144

4.  Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study.

Authors:  Bruna Velosa Ferreira; Emilie Arnault Carneiro; Carolina Pestana; Filipa Barahona; Joana Caetano; Raquel Lopes; Paulo Lúcio; Manuel Neves; Hans Christian Beck; Ana Sofia Carvalho; Rune Matthiesen; Bruno Costa-Silva; Cristina João
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

Review 5.  The role of complement in tumor growth.

Authors:  Ruben Pio; Leticia Corrales; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma.

Authors:  Mikio Mikami; Kazuhiro Tanabe; Koji Matsuo; Yuko Miyazaki; Masaki Miyazawa; Masaru Hayashi; Satoshi Asai; Masae Ikeda; Masako Shida; Takeshi Hirasawa; Nozomi Kojima; Ryuichiro Sho; Sadayo Iijima
Journal:  Gynecol Oncol       Date:  2015-10-18       Impact factor: 5.482

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.